Stocks To Cash In On The $35 Billion NASH Dash
Non-alcoholic steatohepatitis (NASH) is expected to become the leading cause of all liver transplants by 2020 – and there is currently no approved treatment for…
Non-alcoholic steatohepatitis (NASH) is expected to become the leading cause of all liver transplants by 2020 – and there is currently no approved treatment for…
Companies with high levels of floating rate debt have struggled as interest rates have ticked up – but today’s article highlights “a potentially high return,…
Of the exchange-traded fund highlighted in today’s article, the author declares that “Quite simply, this is a fund that has a place in just about…
Buying the dips is a popular – and lucrative – strategy where the key is identifying stocks that are in short-term down trends within long-term…
At the Strategic Investment Conference 2018, some of the greatest minds in the investment community shared their thoughts on the economy, the markets – and…
The two keys behaviors of successful long-term investors, according to the author of today’s article, is that “they pick investments that are likely to provide…
Are rising interest rates good or bad for the price of gold? Given that more interest rate hikes are coming, this is a critical question…
In regards to speculative stocks, the author of today’s article notes that it is these stocks “which often come with very low share prices as…
An at-home beverage machine maker, a display technology developer and manufacturer, and a water heater manufacturer make up the three stocks highlighted in today’s article…
“The beauty of quality companies is that you need to get one decision right – that is the ability to identify their business model, and…